NHS pilots new genetic testing service for cancer patients

BMJ ◽  
2013 ◽  
Vol 346 (may20 7) ◽  
pp. f3323-f3323
Author(s):  
K. Chinthapalli
Keyword(s):  
Genetic Testing ◽  
Cancer Patients ◽  
Testing Service ◽  
Genetic Testing Service

Predicting the Performance of a Genetic Testing Service for Cancer Susceptibility

2007 ◽  
Vol 11 (4) ◽  
pp. 381-386
Author(s):  
Chris D. Bajdik ◽  
Steve Sung ◽  
John J. Spinelli ◽  
David Huntsman ◽  
Steven Gallinger ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Cancer Susceptibility ◽  
Testing Service ◽  
Genetic Testing Service

Myriad (A): Breast Cancer Testing in the United States

2017 ◽  
pp. 1-15
Author(s):  
Daniel Diermeier ◽  
Shobita Parthasarathy
Keyword(s):  
Breast Cancer ◽  
United States ◽  
Genetic Testing ◽  
The United States ◽  
Political Climate ◽  
The Public ◽  
Testing Service ◽  
Brca Gene ◽  
Myriad Genetics ◽  
Genetic Testing Service

Describes Myriad Genetics and its struggle to develop a genetic testing service while facing challenges from competitors and activist organizations. After Myriad's discovery of the BRCA gene, capable of genetic testing for breast cancer in women, Myriad needed to choose a strategy to provide this service to the public. With several major competitors offering similar services, intense media scrutiny, and a charged activist and political climate, a poor Myriad decision could have major repercussions.

scholarly journals Valuable Genomes: Taxonomy and Archetypes of Business Models in Direct-to-Consumer Genetic Testing (Preprint)

2019 ◽  
Author(s):  
Scott Thiebes ◽  
Philipp A Toussaint ◽  
Jaehyeon Ju ◽  
Jae-Hyeon Ahn ◽  
Kalle Lyytinen ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Business Models ◽  
Service Providers ◽  
Phase 1 ◽  
Specific Information ◽  
Business Practices ◽  
Testing Service ◽  
Direct To Consumer ◽  
Service Business ◽  
Genetic Testing Service

BACKGROUND Recent progress in genome data collection and analysis technologies has led to a surge of direct-to-consumer (DTC) genetic testing services. Owing to the clinical value and sensitivity of genomic data, as well as uncertainty and hearsay surrounding business practices of DTC genetic testing service providers, DTC genetic testing has faced significant criticism by researchers and practitioners. Research in this area has centered on ethical and legal implications of providing genetic tests directly to consumers, but we still lack a more profound understanding of how businesses in the DTC genetic testing markets work and provide value to different stakeholders. OBJECTIVE The aim of this study was to address the lack of knowledge concerning business models of DTC genetic testing services by systematically identifying the salient properties of various DTC genetic testing service business models as well as discerning dominant business models in the market. METHODS We employed a 3-phased research approach. In phase 1, we set up a database of 277 DTC genetic testing services. In phase 2, we drew on these data as well as conceptual models of DTC genetic testing services and iteratively developed a taxonomy of DTC genetic testing service business models. In phase 3, we used a 2-stage clustering method to cluster the 277 services that we identified during phase 1 and derived 6 dominant archetypes of DTC genetic testing service business models. RESULTS The contributions of this research are 2-fold. First, we provided a first of its kind, systematically developed taxonomy of DTC genetic testing service business models consisting of 15 dimensions in 4 categories. Each dimension comprises 2 to 5 characteristics and captures relevant aspects of DTC genetic testing service business models. Second, we derived 6 archetypes of DTC genetic testing service business models named as follows: (1) low-cost DTC genomics for enthusiasts, (2) high-privacy DTC genomics for enthusiasts, (3) specific information tests, (4) simple health tests, (5) basic low-value DTC genomics, and (6) comprehensive tests and low data processing. CONCLUSIONS Our analysis paints a much more complex business landscape in the DTC genetic testing market than previously anticipated. This calls for further research on business models and their effects that underlie DTC genetic testing services and invites specific regulatory interventions to protect consumers and level the playing field.

scholarly journals Valuable Genomes: Taxonomy and Archetypes of Business Models in Direct-to-Consumer Genetic Testing

10.2196/14890 ◽  
2020 ◽  
Vol 22 (1) ◽  
pp. e14890 ◽  
Author(s):  
Scott Thiebes ◽  
Philipp A Toussaint ◽  
Jaehyeon Ju ◽  
Jae-Hyeon Ahn ◽  
Kalle Lyytinen ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Business Models ◽  
Service Providers ◽  
Phase 1 ◽  
Specific Information ◽  
Business Practices ◽  
Testing Service ◽  
Direct To Consumer ◽  
Service Business ◽  
Genetic Testing Service

Background Recent progress in genome data collection and analysis technologies has led to a surge of direct-to-consumer (DTC) genetic testing services. Owing to the clinical value and sensitivity of genomic data, as well as uncertainty and hearsay surrounding business practices of DTC genetic testing service providers, DTC genetic testing has faced significant criticism by researchers and practitioners. Research in this area has centered on ethical and legal implications of providing genetic tests directly to consumers, but we still lack a more profound understanding of how businesses in the DTC genetic testing markets work and provide value to different stakeholders. Objective The aim of this study was to address the lack of knowledge concerning business models of DTC genetic testing services by systematically identifying the salient properties of various DTC genetic testing service business models as well as discerning dominant business models in the market. Methods We employed a 3-phased research approach. In phase 1, we set up a database of 277 DTC genetic testing services. In phase 2, we drew on these data as well as conceptual models of DTC genetic testing services and iteratively developed a taxonomy of DTC genetic testing service business models. In phase 3, we used a 2-stage clustering method to cluster the 277 services that we identified during phase 1 and derived 6 dominant archetypes of DTC genetic testing service business models. Results The contributions of this research are 2-fold. First, we provided a first of its kind, systematically developed taxonomy of DTC genetic testing service business models consisting of 15 dimensions in 4 categories. Each dimension comprises 2 to 5 characteristics and captures relevant aspects of DTC genetic testing service business models. Second, we derived 6 archetypes of DTC genetic testing service business models named as follows: (1) low-cost DTC genomics for enthusiasts, (2) high-privacy DTC genomics for enthusiasts, (3) specific information tests, (4) simple health tests, (5) basic low-value DTC genomics, and (6) comprehensive tests and low data processing. Conclusions Our analysis paints a much more complex business landscape in the DTC genetic testing market than previously anticipated. This calls for further research on business models and their effects that underlie DTC genetic testing services and invites specific regulatory interventions to protect consumers and level the playing field.

Successful implementation of a national HLA-B*5701 genetic testing service in Canada

2010 ◽  
Vol 75 (1) ◽  
pp. 12-18 ◽  
Author(s):  
R. G. Lalonde ◽  
R. Thomas ◽  
A. Rachlis ◽  
M. J. Gill ◽  
M. Roger ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Successful Implementation ◽  
Testing Service ◽  
Genetic Testing Service
Sign in / Sign up

Export Citation Format

Share Document